UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012407
Receipt number R000014376
Scientific Title A project to prevent the worsening of diabetic nephropathy in Kure city: A study of the effectiveness of the program to prevent the aggravation of CKD
Date of disclosure of the study information 2013/11/26
Last modified on 2021/04/01 09:31:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A project to prevent the worsening of diabetic nephropathy in Kure city: A study of the effectiveness of the program to prevent the aggravation of CKD

Acronym

Effectiveness of CKD disease management program

Scientific Title

A project to prevent the worsening of diabetic nephropathy in Kure city: A study of the effectiveness of the program to prevent the aggravation of CKD

Scientific Title:Acronym

Effectiveness of CKD disease management program

Region

Japan


Condition

Condition

chronic kidney disease

Classification by specialty

Nephrology Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to develop the CKD self-management program and to verify the effectiveness.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The number of subjects who moved to ESKD, initiated RRT, newly onset of CVD (cerebrovascular disease, coronary artery disease, and heart failure), and the number of death.

Key secondary outcomes

Physiological indicators: BP, Body Mass Index (BMI), urine protein, Scr, eGFR, BUN, UA, and non high-density lipoprotein cholesterol (non HDL-c), and other data.
Psychological indicator: the self-efficacy scale on health behavior in patients with chronic disease.
The process indicators: the proportion of days in a month that subjects performed the following self-management behaviors.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Long-term patient education by trained nurses

Interventions/Control_2

Usual education by trained nurses

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Participants are the beneficiaries of Kure-city national health insurance, aged over 40 years who received a specific medical check-up of 2012 and 2013, met criteria as described in the below, and provided informed consent to participate.
Inclusion criteria were
(1) urine protein level is higher than 2+, or
(2) urine protein level is 1+ and an estimated glomerular filtration rate (eGFR) between 15 to 44 mL/min/1.73 m2 at the registration point, and
(3) no diagnosis of diabetic nephropathy at the registration point.

Key exclusion criteria

Exclusion criteria were
(1) having introduced RRT,
(2) died,
(3) cognitively impaired or mental disorders, and
(4) when his/her primary physician judged that the enforcement of the program causes problems on the patients.

Target sample size

140


Research contact person

Name of lead principal investigator

1st name Michiko
Middle name
Last name MORIYAMA

Organization

Hiroshima University, Graduate School of Biomedical & Health Sciences

Division name

Division of Nursing Science

Zip code

734-8553

Address

Kasumi 1-2-3 Minami-ku, Hiroshima-shi, Hiroshima, 734-8553 Japan

TEL

082-257-5365

Email

morimich@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Michiko
Middle name
Last name Moriyama

Organization

Hiroshima University, Graduate School of Biomedical and Health Sciences

Division name

Division of Nursing Science

Zip code

734-8553

Address

Kasumi 1-2-3 Minami-ku, Hiroshima-shi, Hiroshima, 734-8553 Japan

TEL

082-257-5365

Homepage URL


Email

nkymssm1881@hotmail.co.jp


Sponsor or person

Institute

Hiroshima University, Graduate School of Biomedical and Health Sciences

Institute

Department

Personal name



Funding Source

Organization

JSPS (Japan)(April 2013 to March 2014)
Kure-city local government (April 2014 to March 2015)

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hiroshima University Hospital, Center for Integrated Medical Research

Address

Kasumi 1-2-3 Minami-ku, Hiroshima-shi, Hiroshima, 734-8551 Japan

Tel

082-257-1725

Email

protocol@cimr.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 11 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

41

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Writing a manuscript

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 08 Month 01 Day

Date of IRB

2013 Year 09 Month 25 Day

Anticipated trial start date

2013 Year 09 Month 25 Day

Last follow-up date

2020 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2021 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 11 Month 26 Day

Last modified on

2021 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014376


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name